AMLX
NASDAQ · Pharmaceuticals
Amylyx Pharmaceuticals Inc
$13.47
-0.06 (-0.44%)
Open$13.44
Previous Close$13.53
Day High$13.59
Day Low$13.20
52W High$17.49
52W Low$2.60
Volume—
Avg Volume672.0K
Market Cap1.54B
P/E Ratio—
EPS$-1.80
SectorPharmaceuticals
Analyst Ratings
Strong Buy
16 analysts
Price Target
+175.8% upside
Current
$13.47
$13.47
Target
$37.15
$37.15
$28.49
$37.15 avg
$49.81
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 140.51M | 449.35M | 403.13M |
| Net Income | -485,264,659 | 64.17M | 62.78M |
| Profit Margin | -345.4% | 14.3% | 15.6% |
| EBITDA | -506,644,708 | 107.91M | 96.37M |
| Free Cash Flow | — | 81.20M | 53.03M |
| Rev Growth | +574.3% | +13.9% | +9.9% |
| Debt/Equity | — | 0.29 | 0.32 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |